FDA Approves Pluvicto/Locametz for Metastatic Castration-Resistant Prostate Cancer.
Unknown authors
2022PubMed38 citations
Topics & Concepts
Prostate cancerMedicineCastrationOncologyInternal medicineCancerUrologyHormoneScience, Research, and MedicineProstate Cancer Treatment and Research